There are many causes of rhabdomyolysis, including crush injury, heat stroke, muscle ischaemia, necrotizing myositis following acute viral infections such as glandular fever and influenza, and as a result of hypokalaemic myopathy induced by chronic diuretic ingestion'. Rhabdomyolysis may also be precipitated by anaesthesia in disorders such as malignant hyperpyrexia, the muscular dystrophies, and neuroleptic malignant syndrome. We describe the development of massive rhabdomyolysis after elective coronary artery bypass surgery and discuss the possible diagnoses.
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CASE REPORT
A 55-year-old, 95 kg man presented for coronary artery bypass surgery. His past history included hypertension and two myocardial infarctions ten years and one year previously. Angiography demonstrated severe triple vessel coronary disease and poor left ventricular contractility. Daily medication included frusemide 40 mg, lisinopril 10 mg and aspirin 150 mg. Two years earlier, lumbar discectomy had been performed without incident. He had four siblings, each of whom had undergone general anaesthesia apparently uneventfully. Preoperative examination was unremarkable, and routine biochemical investigations were normal, except that the serum creatine kinase (CK) was mildly elevated (309 VII, normal range 25-200 V/l).
On the day of surgery he was premedicated with lorazepam 2 mg orally, morphine 10 mg IM, and droperidol 2.5 mg IM. Before induction, routine monitoring was established and radial arterial and subclavian venous cannulae were inserted under local anaesthesia. Following intravenous midazolam 2 mg, fentanyl 1 mg, and pancuronium 12 mg, the trachea was intubated and the lungs ventilated with enflurane 2070 and nitrous oxide in oxygen. A pulmonary artery catheter was positioned via the internal jugular vein, and oesophageal and nasopharyngeal temperature probes inserted. Surgery proceeded uneventfully and prior to commencing cardiopulmonary bypass (CPB), cardiovascular parameters, temperature, blood gases and biochemistry were normal. An hour after anaesthesia began, CPB was established. Hypothermic, non-pulsatile CPB was used, employing a membrane oxygenator and Ringers solution prime, with a flow rate of 2.4 lImin/m 2 at 37°C, tailored to 1.5 lImin/m 2 at 28°C. During this period serum electrolytes and arterial gases were unremarkable, though blood lactate levels rose to 4.7 mmolll (NR 0.3-1.3 mmolll). The mixed venous oxygen saturation monitored during bypass was maintained at 75% or greater throughout. After some 60 minutes, rewarming was begun, sinus rhythm recommenced spontaneously, and the patient was weaned from CPB with the temporary assistance of an adrenaline infusion which was discontinued uneventfully 15 minutes after separation from bypass. Surgery was completed and the patient transferred to the intensive care unit. He was sedated with propofol and ventilated overnight, in accordance with routine procedure. During this period gas exchange and serum electrolytes were normal. Apart from occasional unifocal ventricular ectopics and a brief selfterminating episode of supraventricular tachycardia, he remained in sinus rhythm with a normal blood pressure, and cardiac indices were unremarkable. A mild pyrexia (38.2°C orally) settled spontaneously within 24 hours.
The morning after surgery the patient was extubated whereupon he complained of widespread muscle pain, stiffness and tenderness. Symptoms gradually resolved over the following few days with simple analgesics. At the same time, the serum concentrations of a number 
of enzymes were noted to be elevated (Table 1 ). There were significant increases in CK, lactate dehydrogenase (LDH), and aspartate transaminase (AST). The myocardial isoenzyme fractions (CK-MB and LDH 1 ) were within normal limits, and serial ECGs were not suggestive of acute myocardial infarction. The patient also developed myoglobinuria which was confirmed biochemically and persisted until the third postoperative day. The blood lactate level, which had risen during CPB, returned to normal on the second day. An alkaline diuresis was established, but otherwise specific treatment was not instituted. Subsequent recovery was uneventful, although resolution of the elevated enzyme levels was protracted and the CK remained mildly raised at discharge 12 days after surgery. Because of the possibility of the rhabdomyolysis having been caused by an episode of malignant hyperpyrexia (MH) triggered by general anaesthesia, delayed muscle biopsy was undertaken and in vitro testing performed in accordance with the protocol of the European Malignant Hyperpyrexia Group2. Results are shown in Table 2 , and indicate the 
DISCUSSION
Postoperatively there was a dramatic and sustained rise in the CK isoenzyme fraction derived from skeletal muscle, and a concomitant increase in the LDs isoenzyme component, consistent with skeletal muscle damage. The demonstration of myoglobinuria confirmed the diagnosis of acute, massive rhabdomyolysis. In this report, rhabdomyolysis may have been the major manifestation of an episode of MH triggered during general anaesthesia. By the criteria of the European MH Group, the combination of abnormal static and dynamic halothane contracture tests and a normal caffeine contracture test would label the patient MHE2. However, a proportion of such patients are, in fact, susceptible to MH, and addition of the recently described ryanodine contracture test to the halothane and caffeine tests can distinguish which of the so-called MHE patients are truly MHS3. Prior to surgery there was no clinical evidence to suggest the risk of MH. The baseline serum CK level was slightly elevated, but determination of CK is not reliable as a predictor of individual susceptibility, though MH patients as a group do have abnormal CK levels 4 • Moreover, although the patient had been safely exposed to MHinducing agents during previous general anaesthesia, the absence of triggering does not exclude the possi-bility of MH susceptibility5. The anaesthetic management of patients with known MH susceptibility undergoing cardiac surgery is well described 6 -s , but there are only two reports of the occurrence of MH during cardiac surgery in patients not previously known to be MH susceptible. One describes an episode which developed in a two-year-old boy during correction of a Tetralogy of Fallot 9
• Tachycardia, metabolic acidosis and pyrexia persisted until the second postoperative day, when administration of dantrolene resulted in the rapid and complete resolution of these abnormalities. A second report describes signs suggestive of MH during mitral valve replacement in an adult who also had centronuclear myopathylO. The patient was successfully treated with dantrolene given during CPB. However, MH susceptibility was not confirmed in either of these cases.
MH consists of a combination of abnormalities reflecting an overall hypermetabolic state. Signs usually develop soon after exposure to trigger agents, but there is a wide variation in clinical presentation, and the onset can be delayed or insidious ll • Classically, signs include high core temperature, muscle rigidity, hypoxaemia, hypercarbia, tachycardia and arrhythmias. However, hypothermic CPB can mask these signs and prevent or delay the identification of an episode of MH. In order to facililtate the diagnosis of a crisis in these circumstances, regular measurement of acid-base status, venous oxygen saturation, oxygen consumption, and lactate levels during CPB has been advocated 79 • Similarly, pyrexia, shivering, conduction abnormalities, electrolyte disturbances, impairment of gas exchange and coagulopathy are common in patients following cardiac surgery and CPB, and therefore recognition of MH during the immediate postoperative period can be difficult 1 2 • Moreover, the use of nondepolarizing neuromuscular blocking agents during anaesthesia can delay or attenuate episodes of MH in susceptible patients'\ and cooling during exposure to trigger agents can prevent or minimize the hypermetabolic response during an MH crisis '4 • Some or all of these factors may have contributed to the absence of "classic" signs of MH in this report.
These findings may represent an episode of MH triggered by enflurane, other features being masked by hypothermic CPB. However, an alternative explanation exists. In addition to MHS patients, rhabdomyolysis and myoglobinuria can follow anaesthesia in those with previously undiagnosed myopathies, for example the muscular dystrophies, and such episodes can initially be mistaken for MH'5. Reports of anaesthesia in patients with occult myopathies often describe hyperkalaemia, life-threatening arrhythmias and rhabdomyolysis, commonly, though not exclusively, asso-Anaesthesia and Intensive Care, Vol. 23, No. 6, December 1995 ciated with the administration of suxamethonium '6 ,l7. False positive in vitro contracture test results have been demonstrated in some patients with certain forms of myopathy and interpretation of the halothane-caffeine test is difficult in this grouplS. Such patients are often designated MHE on the basis of these results, one study showing seven out of ten MHE patients to have an underlying myopathy3. Moreover, there is an increased incidence of MH-like reactions in this group following anaesthesia or exposure to cold 19. Clinically these patients may appear normal, and specific investigations such as electromyography (EMG), or histological examination of muscle biopsy specimens may provide the only evidence of an underlying myopathy. Whilst EMG studies were not performed, findings on both light and electron microscopy were consistent with the presence of an underlying myopathy, and in conjunction with a mildly elevated baseline serum CK and equivocal MH test, would support the diagnosis of an occult myopathy.
The response to anaesthesia in myopathic patients ranges from asymptomatic biochemical abnormalities to massive rhabdomyolysis, hyperkalaemia and cardiac arrest I6 ,l7. The most dramatic events tend to be associated with the use of suxamethonium, but cardiac arrest has followed the use of both isoflurane 20 and halothane 21 in the absence of depolarizing agents. Rhabdomyolysis in myopathic patients exposed to enflurane has not been described before. Previous normal anaesthesia excludes neither the presence of an asymptomatic myopathy nor susceptibility to MH, though conversely the administration of suxamethonium and/or halogenated hydrocarbon anaesthetic agents can be fatal in both conditions. Usually myopathy-related rhabdomyolysis can be clearly differentiated from MH by the absence of evidence of hypermetabolism in the former group. However, in this report, differentiation is difficult because early signs of MH, such as a rise in EtC0 2 , may have been masked by prolonged hypothermia associated with CPB.
A third but unlikely cause of the postoperative rhabdomyolysis is neuroleptic malignant syndrome precipitated by droperidol. This disorder is a rare but potentially fatal reaction to antipsychotic neuroleptic drugs such as phenothiazines and butyrophenones. It is characterized by extra-pyramidal signs such as dystonia, bradykinesia, and rigidity, hyperthermia associated with autonomic instability, and deterioration in mental status with catatonia or coma. In addition the syndrome typically runs a protracted course with recovery over some five to ten days. It must, however, be regarded as an unlikely diagnosis in this case, because the majority of these features were absent.
We have presented a case in which massive rhabdomyolysis followed general anaesthesia for cardiac surgery. The occurrence of rhabdomyolysis peroperatively should alert the clinician to the possibility of an underlying occult myopathy or susceptibility to MH. Such patients should undergo muscle biopsy, microscopy and contracture testing, though these investigations may be inconclusive. In these circumstances, in vitro ryanodine contracture testing and EMG studies may help to elucidate the precise cause. In this report, differentiation between the two was further complicated by the use of hypothermic CPB which may have attenuated the signs of hypermetabolism normally present in an MH crisis.
